Difference between revisions of "Plasminogen activator inhibitor-2"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 47: | Line 47: | ||
Crosslinking by TG2 has no effect on the protein's function/activity. | Crosslinking by TG2 has no effect on the protein's function/activity. | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:52, 10 March 2015
| Plasminogen activator inhibitor-2 | |
|---|---|
| Substrate peptide name | Plasminogen activator inhibitor-2 |
| Synonyms | Urokinase inhibitor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytosol
Plasma |
| Swissprot ID | P05120 |
| Reactive glutamines | Q83, Q84, Q86 |
| Reactive lysines | Not determined yet |
| Substrate sequence | SCGFMQQIQKGSYP |
| Structure | 1BY7 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:7910824 |
| Notes | Polymerization occurs upon transglutaminase action
Crosslinking by TG2 has no effect on the protein's function/activity. |
